| Globe & Mail (Toronto, Canada) 2005 Leonard Zehr |
| Title | Subject | Authors |
|---|
| Biovail cuts work force, returns to drug roots. | News, opinion and commentary | Leonard Zehr |
| Biovail drug cleared in U.S.(Biovail Corp markets Tramadol ER) | News, opinion and commentary | Leonard Zehr |
| Biovail forms committee to oversee Melnyk bid.(Biovail Corp. to go private - Eugene Melnyk, chairman) | News, opinion and commentary | Leonard Zehr, Jacquie McNish |
| Biovail founder to forego crash salary as part of firm's governance reforms.(Eugene Melnyk, executive chairman, Biovail Corp) | News, opinion and commentary | Leonard Zehr |
| Biovail's 'quarter of note' stronger than expected.(Biovail Corp. posts better second quarter financial results) | News, opinion and commentary | Leonard Zehr |
| Biovail stock sinks as rival gets FDA's okay.(Food and Drug Administration approves Wellbutrin XL of Anchen Pharmaceuticals Inc.) | News, opinion and commentary | Leonard Zehr |
| Boston offers to buy Guidant.(Boston Scientific Corp. acquires Guidant Corp.) | News, opinion and commentary | Leonard Zehr |
| Does toxic fish hold medical marvels?(Wex Pharmaceuticals Inc.) | News, opinion and commentary | Leonard Zehr |
| Drug firm Patheon 'disappointed' by third quarter.(Patheon Inc. posts profit decline) | News, opinion and commentary | Leonard Zehr |
| FDA's tramadol decision boosts Biovail outlook.(Food and Drug Administration approves marketing of Tramadol) | News, opinion and commentary | Leonard Zehr |
| Generic drug makers target new proposal.(data protection for brand names) | News, opinion and commentary | Leonard Zehr |
| Generic giant moves in from India.(Ranbaxy Laboratories Ltd. forays into Canada) | News, opinion and commentary | Leonard Zehr |
| Glaxo bids for ID Biomedical.(ID Biomedical Corp., GlaxoSmithKline Public Limited Company) | News, opinion and commentary | Leonard Zehr |
| MDS set to take big charge as profit plunges 62%.(MDS Inc. restructuring plans) | News, opinion and commentary | Leonard Zehr |
| Medicure future hangs on key drug's lab results.(Medicure Inc.'s MC-1 flagship test ) | News, opinion and commentary | Leonard Zehr |
| New leader, new life for tired MDS.(chief executive officer Stephen DeFalco of MDS Inc.) | News, opinion and commentary | Leonard Zehr |
| Under pressure, QLT restructures.(QLT Inc. streamlines operations) | News, opinion and commentary | Leonard Zehr |
| U.S. investors buy Kraft Canada assets.(Sun Capital Partners Inc. and EG Capital Group LLC acquires Kraft Foods Inc. grocery assets) | News, opinion and commentary | Leonard Zehr |
| When threats turn to firebombs, Canaccord cuts loose on client.(Canaccord Capital Corp., contract with Phytopharm PLC) | News, opinion and commentary | Leonard Zehr, Shirley Won |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
